U.S. markets closed

Exact Sciences Corporation (EXAS)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
93.67-0.31 (-0.33%)
At close: 4:00PM EDT
93.66 -0.01 (-0.01%)
After hours: 07:59PM EDT

Exact Sciences Corporation

5505 Endeavor Lane
Madison, WI 53719
United States
608 284 5700

IndustryDiagnostics & Research
Full Time Employees4,800

Key Executives

NameTitlePayExercisedYear Born
Mr. Kevin T. ConroyChairman, Pres & CEO1.92MN/A1966
Mr. Jeffrey T. Elliott CFAExec. VP, CFO & COO847.38k485.04k1978
Mr. D. Scott CowardChief Admin. Officer, Exec. VP, Gen. Counsel & Sec.826.6k2.57M1965
Mr. Graham P. LidgardEmeritus Chief Science Officer852.84k1.01M1949
Mr. Jake OrvilleGen. Mang. of Pipeline651.43kN/A1974
Mr. Gary FringsChief Information OfficerN/AN/AN/A
Dr. Scott C. Johnson Ph.D.Chief Science Officer and Sr. VP of R&DN/AN/AN/A
Ms. Megan JonesAssociate Mang. of Investor RelationsN/AN/AN/A
Mr. Tim CaprezChief Compliance Counsel & VPN/AN/AN/A
Mr. Vic ParkerHead of SalesN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype MAP, a tissue test delivering tumor profiling to aid therapy selection for patients with advanced, metastatic, refractory, or recurrent cancer; Oncotype DX AR-V7 Nucleus Detect Test, a liquid-based test for advanced stage prostate cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research; and Hologic, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Corporate Governance

Exact Sciences Corporation’s ISS Governance QualityScore as of September 26, 2021 is 8. The pillar scores are Audit: 4; Board: 7; Shareholder Rights: 6; Compensation: 10.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.